Skip to content
Menu

MEDIROM Healthcare Technologies Inc. MRM

Full chart Compare
Set alert

Price alert · MRM

All alert types
0.23 USD -0.01 (-6.12%)

Regular-session close

0.40 +0.17 +75.61%

After hours · Nov 20, 4:00 PM ET

0.23 Day range 0.2689
0.221 52-week range 2.33
YTD
-88.14%
1 year
-88.56%

Fundamental scorecard

11 of 25 checks passed on MRM’s reported financials

ValueGrowthProfitabilityHealthDividend

11of 25 checks passed

  • Value 4 of 5
  • Growth 4 of 5
  • Profitability 3 of 5
  • Financial health 0 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2025.

Value 4 of 5

  • Passed:P/E below its own 5-year median P/E 1.8 against a 5-year median of 20.1.
  • Passed:P/E under 20 P/E 1.8: an earnings yield of 56.5%.
  • Passed:Price to sales below its own 5-year median Price to sales 0.0 against a 5-year median of 0.6.
  • Passed:Price to book below its own 5-year median Price to book 1.1 against a 5-year median of 14.4.
  • Failed:Free cash flow yield above 4% Free cash flow of -1.40B is -533.2% of the market value.

Growth 4 of 5

  • Passed:Revenue grew over the last year Revenue of 8.30B is +21.5% on the year before.
  • Passed:Revenue grew more than 5% a year over five years +16.3% a year from FY 2019 to FY 2024.
  • Passed:Earnings per share grew over the last year EPS 28.52 against 22.34 in the year before.
  • Passed:Earnings per share grew more than 5% a year over five years +47.7% a year from FY 2019 to FY 2024.
  • No data:Analysts expect higher earnings per share over the next year No analyst estimate.

Profitability 3 of 5

  • Passed:Profitable over the last year Net income of 149M over FY 2024.
  • Failed:Profitable in each of the last five fiscal years A profit in 3 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 65.6%.
  • Passed:Net margin above its 5-year average Net margin of 1.8% against a 5-year average of -5.8%.
  • Failed:Free cash flow is at least 80% of net income Free cash flow of -1.40B is -943.2% of net income.

Financial health 0 of 5

  • Failed:Short-term assets cover short-term liabilities Short-term assets of 1.21B against short-term liabilities of 4.99B.
  • Failed:Short-term assets cover long-term liabilities Short-term assets of 1.21B against long-term liabilities of 2.51B.
  • Failed:Net debt under 40% of equity Net debt of 3.88B is 1597.6% of equity.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -1.33B is -34.0% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is 2.2 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell. Amounts are in the company’s reporting currency.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What MRM owns and owes, as of Jun 30, 2025

Short term and long term

Balance sheet · 8.00B of assets

Debt, equity and cash by year

Now: 3.88B of debt after cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings, in its reporting currency.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

1.00 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 3

Valuation

P/E 41.0×
P/S 595×
P/B 1.8×
P/FCF 0.0×
EV/EBITDA 9185×
EV/Sales 1168×
FCF Yield 0.0%

Profitability

Gross Margin 96.6%
Operating Margin 10.3%
Net Margin 9.3%
ROE 0.0%
ROIC 0.0%
ROA 0.0%

Growth (YoY)

Revenue -100.0%
Operating Income 102.3%
EPS (diluted) -72.2%
Free Cash Flow 0.0%

Financial Health

Current Ratio 1.7×
Quick Ratio 1.7×
Debt / Equity 1.7×
Net Debt / EBITDA 4503×
Interest Coverage 1.1×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31